Sleep Aids - Suriname

  • Suriname
  • Revenue in the Sleep Aids market amounts to US$34.80k in 2024. The market is expected to grow annually by 7.13% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (US$2,103m in 2024).
  • In relation to total population figures, per person revenues of US$0.06 are generated in 2024.

Key regions: Philippines, Indonesia, United Kingdom, Canada, Thailand

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids market in Suriname is experiencing significant growth due to changing customer preferences, emerging trends, and local special circumstances.

Customer preferences:
Customers in Suriname are increasingly seeking sleep aids to address their sleep-related issues. Sleep disorders and insomnia are common problems in the country, leading to a growing demand for sleep aids. Customers are looking for products that can help them improve the quality and duration of their sleep, leading to increased sales of sleep aids.

Trends in the market:
One of the key trends in the Sleep Aids market in Suriname is the growing popularity of natural and herbal sleep aids. Customers are becoming more conscious about the ingredients used in sleep aids and are opting for products that are derived from natural sources. This trend is in line with the global shift towards natural and organic products. As a result, companies are introducing new sleep aids that are made from natural ingredients to cater to this demand. Another trend in the market is the increasing availability of sleep aids in different formats. Traditionally, sleep aids were available in the form of pills or capsules. However, companies are now introducing sleep aids in the form of gummies, teas, and sprays. This variety of formats provides customers with more options and allows them to choose a format that suits their preferences and lifestyle.

Local special circumstances:
Suriname has a high prevalence of sleep disorders and insomnia. Factors such as stress, lifestyle changes, and work-related issues contribute to the sleep problems faced by individuals in the country. As a result, there is a greater need for sleep aids to address these issues. The local special circumstances in Suriname have created a favorable environment for the growth of the Sleep Aids market.

Underlying macroeconomic factors:
The growing Sleep Aids market in Suriname can also be attributed to underlying macroeconomic factors. The country's economy has been experiencing steady growth, leading to an increase in disposable income. As people have more money to spend, they are willing to invest in products that can improve their sleep quality. Additionally, the rising awareness about the importance of sleep and its impact on overall health has also contributed to the growth of the Sleep Aids market. In conclusion, the Sleep Aids market in Suriname is witnessing growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. Customers are increasingly seeking sleep aids to address their sleep-related issues, leading to a higher demand for products. The growing popularity of natural and herbal sleep aids, as well as the availability of sleep aids in different formats, are key trends in the market. The high prevalence of sleep disorders and insomnia in Suriname, along with the country's economic growth and increasing awareness about the importance of sleep, further drive the growth of the Sleep Aids market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)